BRIGHTBR252.00

Bright Brothers Limited

· Capital Goods & Defence
AnnualQuarterly₹ CrorePeersTIJARIAJISLDVREQSTEXMOPIPESTAINWALCHMKRITIPREMIERPOLJAICORPLTD
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Revenue from Operations206.7244.6328.4
Other Income1.81.61.8
Total Income208.6246.2330.2
Expenses
+ Cost of Materials Consumed142.8164.5216.0
+ Purchases of Stock-in-Trade2.72.03.7
+ Changes in Inventories-0.6-1.1
+ Employee Benefit Expense22.125.027.7
+ Finance Costs3.86.68.7
+ Depreciation & Amortisation2.32.52.5
+ Other Expenses12.913.816.5
Total Expenses215.1249.2319.2
EBITDA-2.24.420.3
EBIT-4.61.917.9
Profit
Pretax Income-6.5-3.011.0
+ Current Tax-3.1
+ Deferred Tax-2.00.11.4
Total Comprehensive Income-3.4-2.78.6
Per Share
Basic EPS-6.02-5.4515.20
Diluted EPS-6.02-5.4515.20
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit61.278.8109.7
Gross Margin %29.6232.2033.41
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.